Lipedema / GLP-1 medication

GLP-1 Medication and Lipedema Surgery: Why My Approach Changed

Surgery takes the disease out. The medication takes the weight off.

My approach to lipedema has changed. For years it was immediate surgery. It is now a combined approach: GLP-1 medication before surgery, surgery to remove the lipedema, and GLP-1 medication again afterward. This page explains why, describes the protocol I now use, and shows my own patients photographed at each step — before surgery, after surgery, and after the medication. I want to be clear at the outset that there are no published studies yet on GLP-1 medication in lipedema. What follows is what I have learned, offered because it has been life-changing for so many of the women I treat.

Why my approach changed

Three things about this disease made surgery alone the wrong answer for many women.

1. Lipedema is an inflammatory disease

Lipedema fat cells do not work properly. Fluid collects around them, and the tissue becomes a continuing source of inflammation — the swelling, the pain, the heavy legs. Controlling the inflammatory triggers and their consequences is critical, and before the GLP-1 medications the only anti-inflammatory strategy available was diet modification. These medications appear to have an anti-inflammatory benefit of their own. Very frequently, women taking them describe less functional disability — before anyone has operated on anything.

2. Obesity very often coexists with lipedema

Many of my patients describe large, uncontrolled weight gain, particularly at times of hormonal flux — puberty, pregnancy, menopause. That extra weight changes the surgery. Removing fifteen to twenty pounds of fat in one procedure is more dangerous and carries more complications than a smaller operation. And a patient over 200 pounds carries greater intrinsic health risks going into any surgery, which means a greater risk of surgical complications coming out of it.

3. Surgery is for the lipedema. Medication is for the obesity.

Surgery is the most critical part of treatment because it is the only thing that removes lipedema tissue. But the ordinary obesity fat sitting alongside the disease does not need to be removed surgically. It can be reduced medically with GLP-1 medication. Separating those two jobs is the whole idea.

It may be that patients in Germany, where much of the surgical approach was developed, tend to present at lower weights. When I visited the LipoClinic in Mülheim in 2024, the protocol was still surgery — usually four consecutive procedures — and GLP-1 medication was not being used at all.

What I saw in my own patients

More than anything I read, this is what changed my mind.

• Large-volume fat removal can be very dangerous. Taking fifteen to twenty pounds of fat in a single procedure has led, in my experience, to hospitalizations and blood transfusions. That is not an acceptable routine risk for an elective operation.
• Uncontrolled inflammation comes back. When the inflammation is not addressed, I have watched it show up as early weight regain and as regrowth of lipedema — usually in another part of the body, not the area that was treated.
• Higher-weight patients need too many operations. For a woman at 200 to 300 pounds, the amount of fat that would need to come out surgically requires multiple high-risk procedures. Some women also lose substantial weight after surgery and are left with loose skin that a different order could have avoided.

Enter the GLP-1 medications

When these medications arrived, the first thing I noticed was that weight loss on them was very predictable. In my lipedema patients, tirzepatide — which acts on both the GLP-1 and GIP pathways — seemed to work even better than semaglutide.

It is true that the adoption of GLP-1 medication in lipedema has come before the studies. To date there are no published studies specifically looking at its benefit for lipedema patients. What I can tell you is that, anecdotally and consistently, women describe both weight reduction and a decrease in their inflammatory complaints: better mobility, less swelling, less pain. That consistency, across many patients, is the basis for the combined approach I now use.

My treatment protocol now

A few caveats, stated plainly. This is my approach, and it is based on what is known about the disease and on what I have learned from my own patients. Other lipedema surgeons may treat differently. There are no published studies yet evaluating GLP-1 medication with lipedema, so this is an off-label use at this time. I am not your prescriber, and this page is not a recommendation of any particular product.

Size and shape: what the photographs show

This page exists to take one idea a step further than the main lipedema page: to show the same woman before surgery, after surgery, and then after GLP-1 medication at a lower weight, so you can see for yourself what each one does.

The medication reduces weight by shrinking normal fat cells. Surgery removes the lipedema and changes the shape of the limb. My patients put it better than I can: “With the GLP-1 my size decreased. With surgery my shape changed.”

The other thing the photographs show is what does not change. Lipedema tissue is different from normal fat and does not respond to GLP-1 medication. An untreated area with lipedema keeps its shape no matter how much weight comes off. That is why surgery remains the mainstay of treatment for removing the disease — and why, for a woman at 200 to 300 pounds, medication first means a less risky operation, or fewer of them. Several of my patients have also stayed on the medication after surgery as maintenance, to hold their weight and their result.

All photographs are of my own patients, published with consent and shown without retouching. Read each case left to right.

Case 01 · surgery, then GLP-1

Age 34 — the legs that did not change when the rest of her did

Before 142 lb · early-stage lipedema, lower body

After surgery 132 lb · buttocks, thighs and knees · shape corrected

After GLP-1 116 lb · one year later, no further surgery

Age

34

Treated surgically

Buttocks, thighs, knees · one session

Sequence

Surgery, then GLP-1

Weight on medication

142 to 116 lb

Time on combined treatment

One year

Change she reports

Significant relief of pain and swelling

The middle frame is what surgery does to shape, at essentially the same weight. The last frame is twenty-six pounds off the medication — and the thing to look at is how little her lower legs move between those two frames.

That is this page in one photograph. The weight came off everywhere the medication could reach. It did not reach the lipedema still in her lower legs, and it never will. She is now on a maintenance dose and we are planning her lower legs as the next area to treat.

Case 02 · two surgeries at high weight, then GLP-1

Age 57 — one hundred sixty pounds off, and the order I would now reverse

Before 248 lb · extensive lipedema, lower body (high weight 300 lb)

After surgery #1 226 lb · 17 lb of lipedema fat removed

After surgery #2 and GLP-1 157 lb · six months later; she went on to reach 140 lb

Age

57

Treated surgically

Thighs, buttocks, saddlebags, knees · two sessions, four months apart

Sequence

Two surgeries at high weight, then GLP-1

Weight on medication

248 to 140 lb (160 lb total from a high of 300 lb)

Where she stands

Lipedema remains in untreated areas; further surgery planned at lower weight

She had two surgeries. The first treated the anterior thighs and the saddlebags (lateral thighs); the second, four months later, treated the posterior thighs, knees and buttocks. This follows the German protocol for higher-weight women. In total, 39.5 pounds of lipedema fat were removed in two sessions. The first frame is her at 248 pounds — her high weight was 300. The middle frame is 226 pounds, after the first surgery alone removed 17 pounds of lipedema fat. Between the middle and third frames she had her second surgery and started GLP-1 medication; the third frame is six months later, at 157 pounds. She would go on to lose 160 pounds in all, from 300 to 140.

So many women present at very high weight. Lipedema treatment under the German protocol meant removing large volumes of fat in four surgical sessions. This woman lost a very large amount of weight with the benefit of two surgeries and GLP-1 medication. She is significantly better functionally, and you can see her changed body shape. She will have significant skin excess as a consequence. Today, treating her obesity first with GLP-1 medication and then addressing her lipedema surgically may have been a safer and more efficient plan, with less risk and less recovery.

Case 03 · three surgeries, GLP-1 started after the second

Age 44 — three operations that might have been two

Before 180 lb · progressing lipedema, lower extremities

After surgery and GLP-1 137 lb · three sessions

Sequence Medication started after the second operation

Age

44

Treated surgically

Buttocks, thighs, knees, legs · three staged sessions

Removed

37 lb of tissue

Sequence

Surgery, surgery, then GLP-1

Time on combined treatment

Nine months at 137 lb [update if a later follow-up is available]

Change she reports

Improved function and shape; still managing untreated areas

She presented at 180 pounds with significant pain, swelling and limited mobility, and a large volume of disease. Thirty-seven pounds of tissue cannot come out in one setting under any circumstances, so it was staged.

What I would do differently today. She began the medication after her second operation. Had she started it before the first, the ordinary fat would have come down first, the remaining disease would have been clearly demarcated, and I believe this would have been two operations rather than three. Her case is a fair record of how my own thinking has changed, and I would rather show you that than pretend the sequence was always obvious.

Individual results vary. All photographs are of Dr. Ditesheim’s own patients, published with consent and shown without retouching.

What is not known yet

This area generates a lot of questions, and I want to be honest about which ones I cannot answer.

Which medication is best for lipedema — tirzepatide or semaglutide?

Not known. Tirzepatide has seemed to work better in my patients, but nothing has compared them in this disease. I am deliberately not presenting weight-loss literature here, because it does not answer the lipedema question.

Does microdosing work?

Not known. There are no studies. I would rather say that than present information that does not yet exist.

Can lipedema be controlled for more than two years with combined treatment?

This is the question that matters most, and the one I am watching in my own patients. Surgery alone gave most women relief for up to about two years before the fat regrew and the symptoms returned. Whether a combined anti-inflammatory and surgical strategy holds a result beyond that is what we want to see.

Questions patients ask me about these medications

Broader questions about the surgery itself, staging and recovery are answered on the main lipedema page.